Advertisement

Probiotics for constipation and gut microbiota in Parkinson's disease

Published:September 03, 2022DOI:https://doi.org/10.1016/j.parkreldis.2022.08.022

      Highlights

      • Gut dysbiosis have been confirmed in PD patients.
      • After probiotics treatment, there was a significant increase in one bacterium and a decrease in three.
      • Complex-probiotic supplementation may improve constipation in Parkinsonism.
      • Complex-probiotics may change Gut Microbiota population against PD.

      Abstract

      Introduction

      Constipation is one of the common non-motor symptoms in Parkinson's disease that significantly impacts patient quality of life. Probiotics supplementation may improve constipation symptoms, but its effect on the gut microbiota population is unclear.

      Methods

      In this randomized controlled study, 46 PD patients with constipation according to Rome Ⅲ criteria were recruited. The number of complete bowel movements per week, degree of defecation effort, Bristol stool Scale (BSS), Patient Assessment of Constipation symptom (PAC-SYM) and Patient assessment of constipation quality of life questionnaire (PAC-QOL) were collected pre- and post-intervention to evaluate the constipation symptoms. In addition, fresh feces of subjects before and after intervention and healthy controls were collected for 16s rRNA gene V3–V4 region sequencing to compare bacterial flora differences.

      Results

      Compared with the control group, the treatment group increased the average number of complete bowel movements per week (1.09 ± 1.24 vs. 0.04 ± 0.64, P < 0.001). Probiotics supplementation reduced the BSS score (0.65 ± 0.93 vs. −0.17 ± 0.94, P = 0.004), PAC-SYM score (4.09 ± 6.31 vs. −1.83 ± 4.14, P < 0.001), PAC-QOL score (10.65 ± 16.53 vs. 0.57 ± 12.82, P = 0.042), and degree of defecation effort score (1.00 ± 0.80 vs. 0.00 ± 0.30, P < 0.001). The improvement rate of constipation in the probiotics group was significantly higher than that in the control group (52.2% vs. 8.7%, P = 0.001). PD patients showed intestinal flora disorders compared to healthy controls. After 12 weeks of probiotics treatment, g_Christensenella_sp._Marseille-P2437 significantly increased, while g_Eubacterium_oxidoreducens_group, g_Eubacterium_hallii_group and s_Odoribacter_sp._N54.MGS-14 decreased (p < 0 0.05).

      Conclusions

      Probiotics treatment can effectively improve the constipation symptoms of PD patients and positively affected the gut microbiota.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Parkinsonism & Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Barnett R.
        Parkinson's disease.
        Lancet. 2016; 387: 217
        • Siderowf A.
        • Stern M.B.
        Preclinical diagnosis of Parkinson's disease: are we there yet.
        Curr. Neurol. Neurosci. Rep. 2006; 6: 295-301
        • Pfeiffer R.F.
        Gastrointestinal dysfunction in Parkinson's disease.
        Park. Relat. Disord. 2011; 17: 10-15
        • Knudsen K.
        • Krogh K.
        • Østergaard K.
        • Borghammer P.
        Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives.
        Mov. Disord. 2017; 32: 94-105
        • De Pablo-Fernández E.
        • Passananti V.
        • Zárate-López N.
        • Emmanuel A.
        • Warner T.
        Colonic transit, high-resolution anorectal manometry and MRI defecography study of constipation in Parkinson's disease.
        Park. Relat. Disord. 2019; 66: 195-201
        • Postuma Ronald B.
        Can Parkinson's disease come from the gut.
        Mov. Disord. 2015; 30
        • Scheperjans F.
        • Aho V.
        • Pereira P.A.
        • et al.
        Gut microbiota are related to Parkinson's disease and clinical phenotype.
        Mov. Disord. 2015; 30: 350-358
        • Qian Y.
        • Yang X.
        • Xu S.
        • et al.
        Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
        Brain Behav. Immun. 2018; 70: 194-202
        • Cassani E.
        • Privitera G.
        • Pezzoli G.
        • et al.
        Use of probiotics for the treatment of constipation in Parkinson's disease patients.
        Minerva Gastroenterol. Dietol. 2011; 57: 117-121
        • Barichella M.
        • Pacchetti C.
        • Bolliri C.
        • et al.
        Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT.
        Neurol. 2016; 87: 1274-1280
        • Georgescu D.
        • Ancusa O.E.
        • Georgescu L.A.
        • Ionita I.
        • Reisz D.
        Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope.
        Clin. Interv. Aging. 2016; 11: 1601-1608
        • Ai H.T.
        • Lim S.Y.
        • Jia W.H.
        • Jia L.L.
        • Manap M.A.A.A.
        Probiotics for constipation in Parkinson's disease: a randomized placebo-controlled study.
        Neurol. 2020;
        • Drossman D.A.
        The functional gastrointestinal disorders and the Rome III process.
        Gastroenterology. 2006; 130: 1377-1390
        • Edgar R.C.
        UPARSE: highly accurate OTU sequences from microbial amplicon reads.
        Nat. Methods. 2013; 10: 996-998
        • Caporaso J.G.
        • Kuczynski J.
        • Stombaugh J.
        • et al.
        QIIME allows analysis of high-throughput community sequencing data.
        Nat. Methods. 2010; 7: 335-336
        • Segata N.
        • Izard J.
        • Waldron L.
        • et al.
        Metagenomic biomarker discovery and explanation.
        Genome Biol. 2011; 12: R60
        • Schapira A.
        • Chaudhuri K.R.
        • Jenner P.
        Non-motor features of Parkinson disease.
        Nat. Rev. Neurosci. 2017; 18: 509
        • Barboza J.L.
        • Okun M.S.
        • Moshiree B.
        The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson's disease.
        Expet Opin. Pharmacother. 2015; 16: 2449-2464
        • Ibrahim A.
        • Ali R.
        • Manaf M.
        • et al.
        Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson's disease: a randomised controlled trial.
        PLoS One. 2020; 15e0244680
        • Wallen Z.D.
        • Appah M.
        • Dean M.N.
        • et al.
        Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
        NPJ Parkinsons Dis. 2020; 6: 11
        • Zhang F.
        • Yue L.
        • Fang X.
        • et al.
        Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
        Park. Relat. Disord. 2020; 81: 84-88
        • Stephen Nayfach
        • Zhou Jason
        • Shi Rekha
        • Seshadri Katherine
        • Pollard S.
        New insights from uncultivated genomes of the global human gut microbiome.
        Nature. 2019; https://doi.org/10.1038/s41586-019-1058-x
        • Warner B.B.
        • Deych E.
        • Zhou Y.
        • Hall-Moore C.
        • Weinstock G.M.
        • Sodergren E.
        • Shaikh N.
        • Hoffmann J.A.
        • Linneman L.A.
        • Hamvas A.
        • Khanna G.
        • Rouggly-Nickless L.C.
        • Ndao I.M.
        • Shands B.A.
        • Escobedo M.
        • Sullivan J.E.
        • Radmacher P.G.
        • Shannon W.D.
        • Tarr P.I.
        Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study.
        Lancet. 2016; 387: 1928-1936https://doi.org/10.1016/S0140-6736(16)00081-7
        • Iljazovic A.
        • Roy U.
        • Gálvez E.
        • Lesker T.R.
        • Zhao B.
        • Gronow A.
        • Amend L.
        • Will S.E.
        • Hofmann J.D.
        • Pils M.C.
        • Schmidt-Hohagen K.
        • Neumann-Schaal M.
        • Strowig T.
        Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation.
        Mucosal Immunol. 2021; 14: 113-124https://doi.org/10.1038/s41385-020-0296-4
        • Sommer F.
        • Bäckhed F.
        The gut microbiota--masters of host development and physiology.
        Nat. Rev. Microbiol. 2013; 11: 227-238
        • Kleine Bardenhorst S.
        • Berger T.
        • Klawonn F.
        • Vital M.
        • Karch A.
        • Rübsamen N.
        Data analysis strategies for microbiome studies in human populations-a systematic review of current practice.
        mSystems. 2021; 6https://doi.org/10.1128/mSystems.01154-20
        • Dimidi E.
        • Christodoulides S.
        • Fragkos K.C.
        • Scott S.M.
        • Whelan K.
        The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials.
        Am. J. Clin. Nutr. 2014; 100: 1075-1084
        • Bär F.
        • Von Koschitzky H.
        • Roblick U.
        • et al.
        Cell-free supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study.
        Neuro Gastroenterol. Motil. 2009; 21 (e16-7): 559-566
        • Sampson T.R.
        • Debelius J.W.
        • Thron T.
        • et al.
        Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease.
        Cell. 2016; 167 (e12): 1469-1480
        • Sun M.F.
        • Zhu Y.L.
        • Zhou Z.L.
        • et al.
        Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
        Brain Behav. Immun. 2018; 70: 48-60
        • Gazerani P.
        Probiotics for Parkinson's disease.
        Int. J. Mol. Sci. 2019; 20
        • Kunze W.A.
        • Mao Y.K.
        • Wang B.
        • et al.
        Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening.
        J. Cell Mol. Med. 2009; 13: 2261-2270
        • Grasa L.
        • Abecia L.
        • Forcén R.
        • et al.
        Antibiotic-Induced depletion of murine microbiota induces mild inflammation and changes in toll-like receptor patterns and intestinal motility.
        Microb. Ecol. 2015; 70: 835-848
        • Dimidi E.
        • Christodoulides S.
        • Scott S.M.
        • Whelan K.
        Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation.
        Adv. Nutr. 2017; 8: 484-494
        • Mallick H.
        • Ma S.
        • Franzosa E.A.
        • Vatanen T.
        • Morgan X.C.
        • Huttenhower C.
        Experimental design and quantitative analysis of microbial community multiomics.
        Genome Biol. 2017; 18: 228https://doi.org/10.1186/s13059-017-1359-z